The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns for del(17P)/mutated TP53 or relapsed/refractory (R/R) CLL among experts and lower-volume treaters.
 
Ryan Topping
No Relationships to Disclose
 
Timothy Quill
No Relationships to Disclose
 
Farrukh Awan
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; BeiGene; BMS GmbH & Co. KG; Caribou Biosciences; DAVA Pharmaceuticals; Genmab; Gilead Sciences; Incyte; Karyopharm Therapeutics; Kite/Gilead; Loxo/Lilly
Research Funding - Abbvie/Pharmacyclics; Pharmacyclics
 
Jennifer Brown
Consulting or Advisory Role - Abbvie; Acerta/Astra-Zeneca; Alloplex Biotherapeutics Inc; BeiGene; Bristol-Myers Squibb; EcoR1 Capital; Galapagos NV; Genentech/Roche; Grifols Worldwide Operations; InnoCare Pharma Inc; Kite, a Gilead company; Loxo/Lilly; Magnet Biomedicine; Merck; Numab; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); iOnctura; Loxo/Lilly (Inst); MEI Pharma (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Receives royalties from UpToDate associated with authorship of articles.
Other Relationship - Serves on the Data Safety Monitoring Board for Grifols Therapeutics
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Allogene Therapeutics; AstraZeneca; BeiGene; Genentech; Genmab; Loxo/Lilly; Pharmacyclis/Janssen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Genentech (Inst); Genmab (Inst); Loxo/Lilly (Inst); MingSight (Inst); Octapharma USA (Inst); Oncternal Therapeutics (Inst)
 
Sameer Parikh
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Genentech (Inst); Janssen (Inst); Kite, a Gilead Company (Inst); Merck (Inst); MingSight (Inst); NovalGen (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst)
 
Jennifer Woyach
Consulting or Advisory Role - Abbvie; AstraZeneca; Beigene; Genentech; Janssen; Loxo; Merck; Newave Pharmaceutical; Pharmacyclics
Research Funding - Janssen; Karyopharm Therapeutics; MorphoSys; Schrodinger